Air Products Outpaces Peers as Shorts Quietly Retreat

Air Products and Chemicals has gained 3% over the past week, more than three times the median advance of its closest peers, while short sellers have been trimming rather than adding exposure.

Among its most correlated peers, Linde rose just over 1% on the week, and Air Liquide (AI) added around 3.6%. APD's short interest, at roughly 2% of free float, is low relative to the industrial gases universe. That compares with a lending market that is essentially uncongestested: availability runs at 3,480%, meaning shares to borrow dwarf current demand by a wide margin. Borrowing costs have ticked up about 33% over the past week to 0.53%, but from a very low base, and the absolute level remains negligible. The options market confirms the lack of urgency on the bear side, with the put/call ratio at 0.62, just below its 20-day average and showing no pre-earnings hedging spike.

The short interest trend reinforces this picture. Positions fell nearly 4% over the past week to around 4.4 million shares, continuing a drift lower from the October peak above 5.3 million shares reached briefly on October 1. That peak has since fully unwound, and the short-score reading of 35 places APD in the bottom third of the ORTEX universe on short pressure, consistent with a stock where the bear case has been losing adherents rather than gaining them.

The analyst community is more divided on valuation. Barclays initiated coverage at Overweight with a $353 target in mid-October, and RBC Capital maintains Outperform, though it trimmed its target to $346 from $360 around the same time. Citigroup and UBS both hold Neutral ratings and lowered their targets in early October, to $312 and $305 respectively, both below where the stock now trades at $316. The consensus mean sits at $343, implying modest upside, and forward EPS momentum ranks in the 88th percentile over 30 days, a signal that estimate revisions have been running in the company's favour. The stock's 13% one-month gain has compressed the EV/EBITDA multiple upward, though it has eased slightly over 30 days, and the PE of around 20x reflects a market willing to pay for the hydrogen infrastructure backlog and contracted revenue visibility that the bear case on near-term margins has struggled to dent.

Capital Research and Management remains the largest disclosed holder at around 9.2% of shares. Both Capital Research Global Investors and Capital International Investors reduced their stakes below the 5% disclosure threshold earlier this year, and Vanguard Portfolio Management filed a fresh Schedule 13G on October 30 disclosing a 5.36% position. No Schedule 13D activist is on the register. The November 4 print will test whether the earnings quality and margin trajectory can support a multiple that has re-rated sharply higher in a single month.